StonvexLoading…
StonvexStonvexStonvexCore line items from GGG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-26 | Annual 2024 2024-12-27 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $2.24B | $2.11B | $2.20B | $2.14B |
Operating Income | $624.80M | $570.10M | $646.84M | $572.70M |
Net Income | $521.84M | $486.08M | $506.51M | $460.64M |
EPS (Diluted) | $3.08 | $2.82 | $2.94 | $2.66 |
Total Assets | $3.27B | $3.14B | $2.72B | $2.44B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $624.08M | $675.34M | $537.95M | $339.20M |
Free Cash Flow OCF − CapEx | $637.92M | $514.96M | $466.24M | $176.23M |
Shares Outstanding | 165.15M | 169.39M | 167.95M | 167.70M |